Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
2(18%)
Results Posted
67%(6 trials)

Phase Distribution

Ph phase_2
4
36%
Ph phase_3
3
27%
Ph phase_1
4
36%

Phase Distribution

4

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
4(36.4%)
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
3(27.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(9)

Detailed Status

Completed9
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (36.4%)
Phase 24 (36.4%)
Phase 33 (27.3%)

Trials by Status

completed982%
active_not_recruiting218%

Recent Activity

2 active trials
Showing 5 of 11
completedphase_3

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

NCT05142722
completedphase_3

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

NCT05425745
completedphase_1

A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin

NCT06081166
completedphase_2

Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease

NCT05161715
completedphase_2

A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.

NCT05421078
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT05142722Phase 3

Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

Completed
NCT05425745Phase 3

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

Completed
NCT06081166Phase 1

A Drug-drug Interaction Study Evaluating the PK Effects of Obicetrapib on Atorvastatin and Rosuvastatin

Completed
NCT05161715Phase 2

Proof-of-concept, Open-label Study in Patients With Early Alzheimer's Disease

Completed
NCT05421078Phase 2

A Dose-Finding Study in Japanese Patients to Evaluate the Effect of Obicetrapib as an Adjunct to Stable Statin Therapy.

Completed
NCT06250205Phase 1

Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib

Completed
NCT05972278Phase 1

Investigating the Effect of Obicetrapib on Lipoprotein Metabolism

Active Not Recruiting
NCT06048302Phase 1

PK and Safety in Participants Taking Obicetrapib With Moderate Hepatic Impairment Relative to Normal Hepatic Function

Completed
NCT04753606Phase 2

Randomized Study of Obicetrapib as an Adjunct to Statin Therapy

Completed
NCT05266586Phase 2

Study to Evaluate the Effect of Obicetrapib in Combination With Ezetimibe as an Adjunct to HIS Therapy

Completed
NCT05202509Phase 3

Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease

Active Not Recruiting

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11